Cargando…

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer

We have recently demonstrated that fibroblast growth factor receptor 2 (FGFR2)‐mediated signalling alters progesterone receptor (PR) activity and response of oestrogen receptor α (ER)‐positive (ER+) breast cancer (BCa) cell lines to anti‐ER agents. Little is known about whether the crosstalk between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mieczkowski, Kamil, Kitowska, Kamila, Braun, Marcin, Galikowska‐Bogut, Barbara, Gorska‐Arcisz, Monika, Piasecka, Dominika, Stawiski, Konrad, Zaczek, Anna J., Nejc, Dariusz, Kordek, Radzisław, Romanska, Hanna M., Sadej, Rafal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348598/ https://www.ncbi.nlm.nih.gov/pubmed/35726195 http://dx.doi.org/10.1002/1878-0261.13274

Ejemplares similares

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
por: Piasecka, Dominika, et al.
Publicado: (2019)

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017)

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
por: Braun, Marcin, et al.
Publicado: (2020)

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016)

Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016)

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
por: Braun, Marcin, et al.
Publicado: (2020)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
por: Kitowska, Kamila, et al.
Publicado: (2021)

FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation
por: Mieczkowski, Kamil, et al.
Publicado: (2023)

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
por: Piasecka, Dominika, et al.
Publicado: (2020)

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
por: Braun, Marcin, et al.
Publicado: (2019)

Boning up on JunB
por: Dove, Alan W.
Publicado: (2004)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

JunB Is Critical for Survival of T Helper Cells
por: Hsieh, Tsunghan, et al.
Publicado: (2022)

JunB: a paradigm for Jun family in immune response and cancer
por: Ren, Fu-jia, et al.
Publicado: (2023)

JunB Controls Intestinal Effector Programs in Regulatory T Cells
por: Wheaton, Joshua D., et al.
Publicado: (2020)

HTLV-3 and HTLV-4 antisense proteins activate JunB-, c-Jun- and JunD-dependent transcription
por: Larocque, Émilie, et al.
Publicado: (2011)

JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells
por: Gurzov, Esteban N., et al.
Publicado: (2008)

JunB regulates homeostasis and suppressive functions of effector regulatory T cells
por: Koizumi, Shin-ichi, et al.
Publicado: (2018)

Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment
por: Chen, Hualin, et al.
Publicado: (2022)

JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy
por: Raffaello, Anna, et al.
Publicado: (2010)

JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
por: Singh, Karmveer, et al.
Publicado: (2018)

USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein
por: Chen, Siyuan, et al.
Publicado: (2018)

JunB is essential for IL-23-dependent pathogenicity of Th17 cells
por: Hasan, Zafrul, et al.
Publicado: (2017)

Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression
por: Sadri, Donia, et al.
Publicado: (2019)

JunB is a key regulator of multiple myeloma bone marrow angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2021)

JunB is required for endothelial cell morphogenesis by regulating core-binding factor β
por: Licht, Alexander H., et al.
Publicado: (2006)

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
por: Kenner, Lukas, et al.
Publicado: (2004)

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
por: Kenner, Lukas, et al.
Publicado: (2011)

The AP-1 transcription factor JunB is required for Th17 cell differentiation
por: Yamazaki, Soh, et al.
Publicado: (2017)

MicroRNA 199a-5p induces apoptosis by targeting JunB
por: Yan, Mengjie, et al.
Publicado: (2018)

Cutaneous Immune Cell-Microbiota Interactions Are Controlled by Epidermal JunB/AP-1
por: Uluçkan, Özge, et al.
Publicado: (2019)

Emerging Role of AP-1 Transcription Factor JunB in Angiogenesis and Vascular Development
por: Yoshitomi, Yasuo, et al.
Publicado: (2021)

The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G(1)
por: Zhang, Jingxi, et al.
Publicado: (2018)

The AP-1 transcription factors c-Jun and JunB are essential for CD8α conventional dendritic cell identity
por: Novoszel, Philipp, et al.
Publicado: (2021)

JunB Mediates Basal- and TGFβ1-Induced Smooth Muscle Cell Contractility
por: Ramachandran, Aruna, et al.
Publicado: (2013)

PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer
por: Lian, Shixian, et al.
Publicado: (2015)

Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression
por: Wang, Fangyuan, et al.
Publicado: (2020)

Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
por: Romanska, Hanna M, et al.
Publicado: (2015)

Smurf1 Inhibits Mesenchymal Stem Cell Proliferation and Differentiation into Osteoblasts through JunB Degradation
por: Zhao, Lan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5kagejmdqokf9hu3tae3pahrkj